Creutzfeldt‐Jakob disease in a recipient of human pituitary‐derived gonadotrophin
- 1 August 1990
- journal article
- case report
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 20 (4), 592-593
- https://doi.org/10.1111/j.1445-5994.1990.tb01322.x
Abstract
A forty-year-old female presented with an unsteady gait 13 years after receiving an eight-month course of human pituitary-derived gonadotrophin injections as treatment for infertility. Over the next ten months the patient subsequently developed generalised myoclonic jerks and dementia and finally died. Neuropathological examination revealed changes in the brain consistent with Creutzfeldt-Jakob disease. This is the first reported case of Creutzfeldt-Jakob disease in a recipient of human derived gonadotrophin.Keywords
This publication has 7 references indexed in Scilit:
- The decline and fall of Creutzfeldt‐Jakob disease associated with human growth hormone therapyNeurology, 1988
- The epidemiology of Creutzfeldt‐Jakob diseaseNeurology, 1987
- Creutzfeldt‐Jakob disease: Clinical analysis of a consecutive series of 230 neuropathologically verified casesAnnals of Neurology, 1986
- Ataxic Creutzfeldt‐Jakob diseaseNeurology, 1985
- The ataxic (cerebellar) form of creutzfeldt-jakob diseaseZeitschrift für Neurologie, 1974
- The Ataxic Form of Creutzfeldt-Jakob DiseaseArchives of Neurology, 1973
- An ataxic form of subacute presenile polioencephalopathy (Creutzfeldt-Jakob disease)Journal of Neurology, Neurosurgery & Psychiatry, 1965